Compare · HUM vs MGEN
HUM vs MGEN
Side-by-side comparison of Humana Inc. (HUM) and Miragen Therapeutics, Inc. (MGEN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both HUM and MGEN operate in Medical Specialities (Health Care), so they compete in similar markets.
- HUM carries a market cap of $42.74B.
- HUM has hit the wire 4 times in the past 4 weeks while MGEN has been quiet.
- HUM has more recent analyst coverage (25 ratings vs 0 for MGEN).
- Company
- Humana Inc.
- Miragen Therapeutics, Inc.
- Price
- $355.91+1.64%
- -
- Market cap
- $42.74B
- -
- 1M return
- +43.90%
- -
- 1Y return
- +52.72%
- -
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NYSE
- NASDAQ
- IPO
- 2014
- News (4w)
- 4
- 0
- Recent ratings
- 25
- 0
Humana Inc.
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through Retail, Group and Specialty, and Healthcare Services segments. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, predictive modeling and informatics services, and clinical care services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2020, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was incorporated in 1964 and is headquartered in Louisville, Kentucky.
Latest HUM
- Humana Inc. filed SEC Form 8-K: Regulation FD Disclosure
- Humana completes $83 million Florida infrastructure investment to deepen coordinated patient care approach
- Humana upgraded by Deutsche Bank with a new price target
- Humana Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- Humana, CenterWell and USAA Unite with VFW for National Day of Service Supporting Veterans Experiencing Homelessness
- Humana Invests More Than $1 Million to Advance Health Outcomes Across Louisiana
- Chief Financial Officer Mellet Celeste gave a grant of 15,387 units of Humana Common, decreasing direct ownership by 28% to 39,637 units (SEC Form 4)
- Chief Information Officer Mehta Japan was granted 9,448 units of Humana Common, increasing direct ownership by 122% to 17,176 units (SEC Form 4)
- President, Enterprise Growth Dintenfass David was granted 11,273 units of Humana Common, increasing direct ownership by 80% to 25,407 units (SEC Form 4)
- President & CEO Rechtin James A. was granted 35,633 units of Humana Common (SEC Form 4)
Latest MGEN
- SEC Form SC 13G/A filed by Miragen Therapeutics, Inc.
- SEC Form SC 13G filed
- SEC Form SC 13G filed
- SEC Form SC 13G/A filed
- SEC Form SC 13G/A filed
- SEC Form 4 filed by L Joseph Turner
- SEC Form 4 filed by Evan Peter Harwin
- SEC Form 4 filed by S. Jeffrey Hatfield
- SEC Form 4 filed by Tomas Kiselak
- SEC Form 4 filed by Arlene Morris